PRIMARY STUDY
Components of the Endogenous Cannabinoid System as Potential Biomarkers for Interstitial Cystitis/Bladder Pain Syndrome
Key Findings: The aim of this review was to identify potential biomarkers for Interstitial cystitis/bladder pain syndrome (IC/BPS) for which targets within the endocannabinoid system are showing promising targets in the development of therapeutic agents.
Type of Study: Meta-analysis
Study Result: Positive
Research Location(s): Israel
Year of Pub: 2021
Cannabinoids Studied: Endocannabinoid (unspecified)
Phytocannabinoid Source: Not Applicable
Citation: Sultana S, et al. Components of the Endogenous Cannabinoid System as Potential Biomarkers for Interstitial Cystitis/Bladder Pain Syndrome. Diagnostics (Basel). 2021; 12:(unknown pages). doi: 10.3390/diagnostics12010019
Authors: Sultana S, Berger G, Lehmann C
